Next Article in Journal
Protein Activity of the Fusarium fujikuroi Rhodopsins CarO and OpsA and Their Relation to Fungus–Plant Interaction
Next Article in Special Issue
Long Chain Omega-3 Polyunsaturated Fatty Acid Supplementation Protects Against Adriamycin and Cyclophosphamide Chemotherapy-Induced Bone Marrow Damage in Female Rats
Previous Article in Journal
Molecular Research on Drug Induced Liver Injury
Previous Article in Special Issue
Effect of Omega-3 Fatty Acid Supplementation on Oxylipins in a Routine Clinical Setting
 
 
Review

Update on the Impact of Omega 3 Fatty Acids on Inflammation, Insulin Resistance and Sarcopenia: A Review

Department of Medicine, Surgery, and Health Sciences, University of Trieste, Strada di Fiume 447, 34100 Trieste, Italy
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(1), 218; https://doi.org/10.3390/ijms19010218
Received: 11 November 2017 / Revised: 12 December 2017 / Accepted: 8 January 2018 / Published: 11 January 2018
(This article belongs to the Special Issue Omega-3 Fatty Acids in Health and Disease: New Knowledge)
Elderly and patients affected by chronic diseases face a high risk of muscle loss and impaired physical function. Omega 3 fatty acids (FA) attenuate inflammation and age-associated muscle loss, prevent systemic insulin resistance and improve plasma lipids, potentially impacting on sarcopenia. This paper aims to review recent randomized clinical studies assessing the effects a chronic omega 3 FA supplementation on inflammatory and metabolic profile during conditions characterized by sarcopenia (aging, insulin resistance, type 2 diabetes, chronic renal failure). A comprehensive search of three online databases was performed to identify eligible trials published between 2012 and 2017. A total of 36 studies met inclusion criteria. Omega 3 FA yielded mixed results on plasma triglycerides in the elderly and no effects in renal patients. No changes in systemic insulin resistance were observed. Inflammation markers did not benefit from omega 3 FA in insulin resistant and in renal subjects while decreasing in obese and elderly. Muscle related parameters improved in elderly and in renal patients. In conclusion, in aging- and in chronic disease-associated sarcopenia omega 3 FA are promising independently of associated anabolic stimuli or of anti-inflammatory effects. The evidence for improved glucose metabolism in insulin resistant and in chronic inflammatory states is less solid. View Full-Text
Keywords: omega 3 fatty acids; sarcopenia; inflammation; aging; insulin resistance; chronic kidney disease omega 3 fatty acids; sarcopenia; inflammation; aging; insulin resistance; chronic kidney disease
Show Figures

Figure 1

MDPI and ACS Style

Buoite Stella, A.; Gortan Cappellari, G.; Barazzoni, R.; Zanetti, M. Update on the Impact of Omega 3 Fatty Acids on Inflammation, Insulin Resistance and Sarcopenia: A Review. Int. J. Mol. Sci. 2018, 19, 218. https://doi.org/10.3390/ijms19010218

AMA Style

Buoite Stella A, Gortan Cappellari G, Barazzoni R, Zanetti M. Update on the Impact of Omega 3 Fatty Acids on Inflammation, Insulin Resistance and Sarcopenia: A Review. International Journal of Molecular Sciences. 2018; 19(1):218. https://doi.org/10.3390/ijms19010218

Chicago/Turabian Style

Buoite Stella, Alex, Gianluca Gortan Cappellari, Rocco Barazzoni, and Michela Zanetti. 2018. "Update on the Impact of Omega 3 Fatty Acids on Inflammation, Insulin Resistance and Sarcopenia: A Review" International Journal of Molecular Sciences 19, no. 1: 218. https://doi.org/10.3390/ijms19010218

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop